ROS have been hypothesized to inhibit the cell signaling of the insulin receptor by blocking the pathway between insulin-receptor substrate 1 (IRS-1) and phosphatidylinositol-4,5-bisphosphate 3-kinase, thereby inducing insulin resistance (IR) [17]. This evidence concerns the gene IRS1 and Insulin resistance.